Q1: Can you label multiple surface proteins simultaneously?

Yes. We routinely perform 2-3 color multiplex labeling using spectrally separated fluorophores on different antibody clones. For larger multiplex panels, we offer bead-based EV surface protein profiling. We carefully design color panels to minimize spectral overlap and include single-color compensation controls.

Q2: What controls are included to ensure labeling specificity?

Every project includes appropriate specificity controls tailored to the labeling modality: isotype-matched antibody controls (antibody labeling), scrambled-sequence aptamer controls (aptamer labeling), dye-only incubation controls (NHS ester labeling), and azide-free producer-cell controls (bioorthogonal labeling).

Q3: Does covalent NHS ester labeling alter exosome surface protein function?

NHS ester labeling modifies primary amines on lysine residues and N-termini, which are abundant on most proteins. While the covalent linkage itself is stable and non-reversible, excessive labeling can mask epitopes or ligand-binding sites. We optimize the fluorophore-to-protein ratio empirically for each batch and monitor functional retention when requested.

Q4: How do you validate labeling efficiency at the single-vesicle level?

We employ nano-flow cytometry with fluorescence triggering or calibrated single-particle fluorescence imaging to determine the percentage of fluorescent-positive particles and their per-particle brightness distribution.

Q5: Can you integrate surface protein labeling with luminal cargo staining?

Yes. We offer dual-compartment labeling in which the surface proteome is labeled by one of the modalities described above while luminal RNA is stained with acridine orange, or a membrane-permeant nucleic acid dye. This approach enables parallel tracking of EV surface identity and internal RNA cargo in uptake and delivery studies. Each dye pair is validated for spectral separation and minimal FRET crosstalk.

Exosome Surface Protein Fluorescent Labeling Service

Creative Biostructure provides an Exosome Surface Protein Fluorescent Labeling Service for marker-specific EV detection and characterization. Targeting proteins such as CD9, CD63, CD81, integrins, immunomodulatory ligands, and disease-associated markers, our service enables EV subpopulation analysis and surface proteome profiling with higher molecular specificity than membrane dyes. We combine antibody-based, covalent, bioorthogonal, and aptamer-directed labeling with proper controls and orthogonal validation to deliver reliable, publication-ready data.

What Is Exosome Surface Protein Fluorescent Labeling

Exosome surface protein fluorescent labeling is a targeted method for attaching fluorophores to proteins exposed on the exosome membrane, enabling marker-specific extracellular vesicle detection and analysis. Unlike lipophilic dyes that stain the lipid bilayer, this approach labels defined surface epitopes, amino acid residues, or glycan structures, producing more specific and stable fluorescence signals. Labeling chemistry directly affects target specificity, signal-to-noise ratio, linkage stability, and compatibility with downstream applications such as flow cytometry, super-resolution microscopy, and single-particle fluorescence imaging.

Why Surface Protein Labeling Over Generic Membrane Staining

Compared with lipophilic dyes such as PKH and Di-series dyes, exosome surface protein fluorescent labeling provides more specific, cleaner, and functionally relevant EV analysis.

Molecular specificity: Distinguishes EV subpopulations by defined markers such as CD9, CD63, CD81, EpCAM, integrins, or disease-related proteins.
Reduced artifacts: Lowers non-specific signals, dye-only particles, and dye–protein aggregates commonly seen with membrane dyes.
Single-EV phenotyping: Supports marker-specific analysis by nano-flow cytometry, super-resolution microscopy, and single-particle imaging.
Functional preservation: Uses mild aqueous conditions to better retain uptake, immune interaction, and targeting functions.
Versatile detection: Compatible with microscopy, flow/nano-flow cytometry, plate-reader assays, and dual-compartment tracking.

Labeling Modality Comparison

Modality	Target Specificity	Label Stability	Throughput	Best For	Limitations
Antibody (direct)	High (epitope-specific)	Moderate	High (bulk + single-EV)	Routine phenotyping, flow cytometry	Antibody cost; steric hindrance on small EVs
Covalent (NHS ester)	Moderate (amine-reactive)	Very high (covalent)	High	In vivo tracking, NIR imaging	Non-specific labeling of non-EV proteins
Bioorthogonal click	Selective (nascent EVs)	Very high (covalent)	Moderate	Pulse-chase, in vivo tracking	Requires producer-cell pre-treatment
Aptamer	High (target-specific)	Moderate–high	High	Biosensor integration, multiplex panels	Nuclease susceptibility; fewer validated targets
Enzymatic/Proximity	Very high (site-specific)	High (covalent)	Low-moderate	Single-EV super-resolution imaging	Requires genetic modification or specialized reagents

Our Surface Protein Fluorescent Labeling Services

Creative Biostructure delivers custom surface protein labeling solutions across all five modalities described above. Our service is modular: clients may select a single labeling approach or combine complementary methods within a single project.

Fluorescent Probe Portfolio

We stock validated fluorophores across the full visible-to-NIR spectrum for surface protein conjugation:

Fluorophore Class	Examples	Ex/Em Range (nm)	Conjugation Chemistry	Typical Application
CF Dyes	CF488A, CF568, CF660R	490–660 / 515–680	NHS ester, click chemistry	Super-resolution (STORM, PALM)
ATTO Dyes	ATTO 488, ATTO 647N	501–646 / 523–664	NHS ester, maleimide	Single-molecule imaging
Cyanine	Cy3, Cy5, Cy7	550–750 / 570–773	NHS ester, DBCO-click	NIR in vivo imaging
Tandem Dyes	PE-Cy5, APC-Cy7	488/633 ex; 670/785 em	Antibody pre-conjugated	Multicolor flow cytometry panels
Qdot	QD525, QD655, QD800	UV/405 ex; 525–800 em	Streptavidin–biotin	Multiplex single-EV phenotyping

Service Packages

Package 1 — Targeted Immunophenotyping

Fluorescent antibody labeling of up to three exosome surface markers.
Includes antibody titration, isotype controls, and compensation controls.
Nano-flow cytometry reports marker-positive EVs, MFI, and particle concentration.
Recommended for: EV subpopulation profiling, biomarker validation, and disease-EV immunophenotyping.

Package 2 — Covalent NHS Ester Protein Labeling

Covalent labeling of exosome surface proteins with AF647, Cy5, Cy7, BDP-FL, or client-supplied dyes.
Optimized dye-to-protein ratio with NTA, zeta potential, and nano-flow cytometry QC.
SEC or ultracentrifugation removes free dye; dye-only controls verify background.
Recommended for: In vivo biodistribution, long-term EV tracking, and NIR imaging.

Package 3 — Bioorthogonal Glycan/Azide-Click Labeling

Metabolic Ac4ManNAz labeling followed by EV isolation and DBCO-fluorophore click conjugation.
Includes azide verification and labeling-efficiency assessment.
Optional GPI-anchor azide labeling supports alternative EV tracking.
Recommended for: Pulse-chase studies, in vivo fate mapping, and EV dynamics analysis.

Package 4 — Aptamer Synthesis & Labeling

Custom DNA aptamer design against client-specified exosome surface targets.
5' or 3' fluorophore/biotin conjugation with optional nuclease-resistant modifications.
Binding and labeling performance validated by SPR, MST, or EV-specific optimization.
Recommended for: Biosensors, aptamer-based EV capture, and antibody-free detection.

Package 5 — Site-Specific Enzymatic Labeling

Optional proximity biotinylation enables native exosome surface labeling.
Single-EV fluorescence validated by super-resolution or interferometric imaging.
Recommended for: Single-EV protein mapping, stoichiometric labeling, and native EV functionalization.

Standard Workflow

Consultation & Target Definition: Define target proteins, labeling method, fluorophore, sample type, and application.
Sample Assessment: Evaluate EV size, concentration, and marker expression by NTA and optional protein analysis.
Strategy Optimization: Select and optimize the most suitable labeling approach at pilot scale.
Controlled Labeling: Perform full-scale fluorescent labeling with matched experimental controls.
Purification: Remove free dye, antibodies, or residual reagents by SEC, ultrafiltration, or ultracentrifugation.
QC & Delivery: Verify EV integrity, labeling efficiency, and fluorescence performance, then deliver labeled EVs with a QC report.

Six-step workflow for exosome surface protein fluorescent labeling from consultation to QC delivery. Figure 1. Exosome Surface Protein Fluorescent Labeling Workflow. (Creative Biostructure)

Quality Control and Characterization Standards

Each labeled exosome batch must pass defined QC criteria before release:

Size and concentration: NTA compares pre- and post-labeling profiles to detect aggregation or vesicle disruption.
Labeling efficiency: Nano-flow cytometry or single-particle fluorescence imaging measures fluorescent-positive EVs and MFI.
Specificity: Isotype, scrambled aptamer, or dye-only controls confirm low background signal.
Morphology: Transmission electron microscopy (TEM) or Cryo-EM verifies intact vesicle structure after labeling.
Surface integrity: Zeta potential changes are monitored to assess surface charge stability.
Free-probe removal: Blank purification runs and fluorescence quantification confirm removal of residual dye or probe.
Stability testing: Optional storage studies assess fluorescence retention at 4°C, −20°C, or −80°C.

All results are summarized in a publication-ready QC report, with raw data available upon request.

Applications (Research Use Only)

Single-EV immunophenotyping: Identify CD9+, CD63+, and CD81+ EV subpopulations and link marker profiles to cell origin, disease status, or treatment response.
Multiplex EV profiling: Analyze multiple EV surface epitopes using bead-based fluorescent antibody panels.
In vivo NIR biodistribution: Track labeled exosomes by whole-animal fluorescence imaging and organ-level quantification.
Super-resolution protein mapping: Visualize nanoscale protein distribution on individual exosomes by STORM, PALM, or related imaging methods.
Aptamer-based EV biosensors: Support fluorescent aptamer probes for microfluidic, SPR, or electrochemical EV detection.
Pulse-chase EV dynamics: Track nascent EVs and monitor secretion, surface proteome changes, and tissue distribution.
Engineered EV QC: Verify targeting ligand retention and orientation on drug-delivery exosomes.

How to Get Started

We accept isolated exosomes, conditioned medium, or biofluids, with optional upstream support.

Submit EV source, target surface protein(s), labeling modality, fluorophore(s), sample amount, and downstream readout through our inquiry form.
Our scientific team reviews feasibility and provides a tailored strategy, timeline, and quotation.
Upon approval, we perform labeling, provide progress updates, and deliver labeled EVs with a QC report and raw data files.

What Deliverables Will You Receive

Deliverable	Description
Labeled Exosome Sample	Fluorescently labeled exosomes in an application-compatible research buffer.
QC Report	NTA, labeling efficiency, MFI, TEM/cryo-EM, zeta potential, and specificity control data.
Method Details	Labeling chemistry, reagent lots, reaction conditions, and purification parameters.
Control Data	Isotype, scrambled, dye-only, or azide-free controls based on the workflow.
Optional Data	Stability results, scale-up advice, and downstream assay guidance.

Why Choose Creative Biostructure

Multi-modality expertise: We match each project with the most suitable labeling strategy, including antibody labeling, NHS ester conjugation, bioorthogonal click chemistry, aptamer labeling, and enzymatic modification.
MISEV-aligned rigor: Each workflow includes proper specificity controls, orthogonal EV characterization, and transparent reporting for reliable surface protein analysis.
Single-particle resolution: Nano-flow cytometry, single-particle imaging, and super-resolution microscopy support quantitative, vesicle-level fluorescence assessment.
Literature-informed protocols: Our methods are benchmarked against peer-reviewed EV labeling studies to reduce technical risk.

Case Study

Case: Covalent Fluorescent Exosome Labeling for In Vitro and In Vivo Tracking

Background

Stable fluorescent labeling is critical for studying exosome uptake, biodistribution, and drug delivery behavior. This study used covalent dye attachment to reduce leakage and false signals associated with lipophilic membrane dyes.

Methods

Labeling strategy: Succinimidyl ester fluorophores conjugated to exosome surface amine groups
Fluorophores: BDP-FL and sulfo-cyanine 7.5
Exosome sources: Goat milk, U87, and B16F10 cells
Analysis: Flow cytometry, TEM, DLS/NTA, HPLC, confocal microscopy, and in vivo optical imaging

Results

NIR-labeled exosome biodistribution and liver uptake in mice compared with free dye. Figure 2. Near-infrared imaging shows the biodistribution of SCy 7.5-labeled milk exosomes in mice, with liver-dominant accumulation confirmed by ex vivo organ imaging and liver-section fluorescence analysis. Free dye displayed a distinct distribution pattern, supporting the stability of covalent exosome labeling. (González M I, et al., 2021)

Efficient labeling: Over 99% fluorescent-positive exosome events were detected.
Preserved properties: Labeled exosomes retained morphology and size profiles.
Improved stability: HPLC showed minimal free-dye release for BDP-FL-labeled exosomes.
Cellular uptake: SCy 7.5-labeled exosomes entered hepatocytes in a dose- and time-dependent manner.
In vivo tracking: NIR-labeled exosomes showed biodistribution distinct from free dye.

Conclusion

Covalent exosome surface fluorescent labeling generates stable EV probes for cellular uptake, biodistribution, and optical imaging studies.

Ready to advance your exosome research with molecularly specific surface protein fluorescent labeling? Contact us to discuss your target proteins, labeling modality, and experimental design. We deliver publication-grade labeled EVs with full characterization and transparent reporting.

References

González M I, González-Arjona M, Santos-Coquillat A, et al. Covalently labeled fluorescent exosomes for in vitro and in vivo applications. Biomedicines. 2021, 9(1): 81.
Wu Q, Wang W, Zhang C, et al. Capturing nascent extracellular vesicles by metabolic glycan labeling-assisted microfluidics. Nature Communications. 2023, 14(1): 6541.
Ueda Y, Manabe Y, Saito S, et al. Antibody-Guided Proximity Labeling Enables Selective Chemical Modification of Exosome Surface Proteins. 2026.

Frequently Asked Questions

For any inquiries, our support team is ready to help you get technical support for your research and maximize your experience with Creative Biostructure.

Related Services